USPTO serial 74250016
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Laval, Quebec, CA
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations used to treat aids, viral infections, cancer, cardiovascular problems, cholesterol; analgesics; kits consisting primarily of reagents used for the diagnosis of aids; vaccines and immunological preparations use to prevent infectious diseases | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 12, 1995 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Dec 7, 1994 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 11, 1994 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Nov 19, 1993 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 1993 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Sep 13, 1993 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Aug 23, 1993 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 1993 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jan 5, 1993 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Nov 18, 1992 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 18, 1992 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 29, 1992 | DOCK | ASSIGNED TO EXAMINER | — |